Titova, N;
Schapira, AHV;
Chaudhuri, KR;
Qamar, MA;
Katunina, E;
Jenner, P;
(2017)
Nonmotor Symptoms in Experimental Models of Parkinson's Disease.
International Review of Neurobiology
, 133
pp. 63-89.
10.1016/bs.irn.2017.05.018.
![]() |
Text
Schapira_1-s2.0-S0074774217300624-main.pdf - Published Version Access restricted to UCL open access staff Download (1MB) |
Abstract
Nonmotor symptoms of Parkinson's disease (PD) range from neuropsychiatric, cognitive to sleep and sensory disorders and can arise from the disease process as well as from drug treatment. The clinical heterogeneity of nonmotor symptoms of PD is underpinned by a wide range of neuropathological and molecular pathology, affecting almost the entire range of neurotransmitters present in brain and the periphery. Understanding the neurobiology and pathology of nonmotor symptoms is crucial to the effective treatment of PD and currently a key unmet need. This bench-to-bedside translational concept can only be successful if robust animal models of PD charting the genesis and natural history of nonmotor symptoms can be devised. Toxin-based and transgenic rodent and primate models of PD have given us important clues to the underlying basis of motor symptomatology and in addition, can provide a snapshot of some nonmotor aspects of PD, although the data are far from complete. In this chapter, we discuss some of the nonmotor aspects of the available experimental models of PD and how the development of robust animal models to understand and treat nonmotor symptoms needs to become a research priority.
Archive Staff Only
![]() |
View Item |